Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avience BiomedicalsNSE:AVIENCE -0.38%18 Interest Coverage is 7.82 as of Mar. 2025, which is 55% above its 10-year median of 5.03. GuruFocus rates NSE:AVIENCE with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 65.24% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Avience Biomedicals's
Operating Income
for the
six
months ended in Mar. 2025 was ₹107.8 Mil. Avience Biomedicals's Interest Expense for the
six
months ended in Mar. 2025 was ₹-13.8 Mil.
Avience Biomedicals's interest coverage for the quarter that ended in Mar. 2025 was 7.82.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Avience Biomedicals's Interest Coverage or its related term are showing as below:
NSE:AVIENCE'
s Interest Coverage Range Over the Past 10 Years
Min: 3.94 Med: 5.03 Max: 7.82
Current: 7.82
NSE:AVIENCE's Interest Coverage is ranked worse than 65.24% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.545
vs NSE:AVIENCE: 7.82
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Avience Biomedicals Interest Coverage Related Terms
Avience Biomedicals Interest Coverage Historical Data
* Premium members only.
The historical data trend for Avience Biomedicals's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Avience Biomedicals Interest Coverage Chart
Avience Biomedicals Annual Data
Trend
Mar23
Mar24
Mar25
Interest Coverage
5.03
3.94
7.82
Avience Biomedicals Semi-Annual Data
Mar23
Mar24
Mar25
Interest Coverage
5.03
3.94
7.82
NSE:AVIENCE vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Avience Biomedicals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avience Biomedicals Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Avience Biomedicals's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals (NSE:AVIENCE) has a Interest Coverage of 7.82 as of Mar. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Avience Biomedicals and its competitors. This is 55% above median its historical median of 5.03. Over the past decade, Avience Biomedicals' Interest Coverage has ranged from 3.94 to 7.82. According to the industry distribution chart, Avience Biomedicals ranks #304 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 65.2%.
Is Avience Biomedicals' Interest Coverage too high?
Avience Biomedicals' current Interest Coverage of 7.82 is 55% above median its 10-year median of 5.03. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 7.82. The Medical Devices & Instruments industry median Interest Coverage is 16.55. Avience Biomedicals' value of 7.82 is 52.7% below this industry median. Based on the distribution chart, Avience Biomedicals ranks #304 out of 466 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avience Biomedicals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #304 out of 466 companies for Interest Coverage. This places Avience Biomedicals in the lower half of its industry. The industry median Interest Coverage is 16.55. Avience Biomedicals' value of 7.82 is 52.7% below this benchmark. Historically, Avience Biomedicals' own Interest Coverage has ranged from 3.94 to 7.82 over the past decade. While the company's 10-year median is 5.03 vs. the industry median of 16.55, Avience Biomedicals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.55, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avience Biomedicals's current Interest Coverage of 7.82 is 52.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current Interest Coverage is 7.82, which is 55% above median its own 10-year median of 5.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Interest Coverage of 7.82. The current Interest Coverage is 7.82, which is 55% above median its 10-year median of 5.03 and 52.7% below the Medical Devices & Instruments industry median of 16.55. Avience Biomedicals' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Interest Coverage is 7.82 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score
Get the complete analysis for NSE:AVIENCE
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AVIENCE has been successfully added to your 
